COVID-19 resources


Latest videos

Manufacturing Adenoviral Vector Vaccines
 


Vaccines: Efficacy and effectiveness
 


B-roll AstraZeneca vaccine manufacturing facility



What is COVID-19, and how can it be prevented and treated?



Biomanufacturing a COVID-19 vector vaccine




Contact us


Email the Global Media Relations team at: 


Gonzalo Viña

Head of Global Media Relations  

+44 (0)1223 344 800


Kim Blomley

Director, Global Media Relations (Corporate)

+44 (0)1223 344 800


Angela Fiorin

Director, Global Media Relations (BioPharmaceuticals)

+44 (0)1223 344 800


Chris Calland

Director, Global Media Relations (Oncology)

+44 (0)1223 344 800



Fiona Cookson

Director, Global Media Relations
(COVID-19 vaccine)

+44 (0)1223 344 800


Sinead Keller

Director, Global Media Relations
(COVID-19 vaccine)

+44 (0)1223 344 800


Christina Malmberg Hägerstrand

Media Relations Director, Sweden and Nordic-Baltic

+46 855 253 106


Holly Campbell

Head, US Corporate Communications

+1 302 885 2677



Lisa Taylor

Senior Director, Corporate Communications (Alexion)

+1 857 338 9025

Amanda Talamonte

Manager, Global Media Relations

+44 (0)1223 344 800

Flavia Garcia

Manager, Global Media Relations

+44 (0)1223 344 800